Stay updated on Nivolumab in Metastatic Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Metastatic Bladder Cancer Clinical Trial page.

Latest updates to the Nivolumab in Metastatic Bladder Cancer Clinical Trial page
- Check3 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.3%

- Check11 days agoChange DetectedAdded a site-wide funding status notice and updated the page revision to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.3%

- Check18 days agoChange DetectedAdded a 'Show glossary' option and updated labels for QC criteria mentions and FEAR Act notices, including capitalization changes and a revision tag update from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page shows Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.0%

- Check53 days agoChange DetectedThe Locations section was updated to add new site listings across multiple states and countries (examples include Akita, Aomori, Kanagawa, Kyoto, Tokyo, New South Wales, and South Australia). Older location listings were removed.SummaryDifference2%

- Check75 days agoChange DetectedThe page revision label updated from v3.3.1 to v3.3.2, a minor system version change with no impact on study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in Metastatic Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Metastatic Bladder Cancer Clinical Trial page.